Tmunity Therapeutics

company

About

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$100M
Industries
Biotechnology,Genetics,Health Care,Manufacturing,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit best-in-class control over T cell activation and direction in vivo, as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors. The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease. The founding team includes experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, who collectively have an unparalleled track record of executing safe and effective cell and gene therapy clinical trials. In addition, Tmunity’s manufacturing platform has a proven track record of success in supporting multi-center clinical studies across diverse therapeutic indications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$220M
Tmunity Therapeutics has raised a total of $220M in funding over 2 rounds. Their latest funding was raised on Oct 31, 2019 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 31, 2019 Series B $75M 1 Detail
Apr 19, 2018 Series A $35M 2 Detail
Jan 23, 2018 Series A $100M 2 Detail
Jan 12, 2016 Series Unknown $10M 1 Detail

Investments

Number of Investments
Number of Lead Investments
4
0
Tmunity Therapeutics has made 4 investments. Their most recent investment was on Sep 1, 2022, when Everphone raised $32M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 1, 2022 Everphone
Series C $32M B2B
Dec 1, 2021 Printify
Series A $5M E-Commerce
May 15, 2018 Blueground
Series Unknown Hospitality
Apr 5, 2017 Blueground
Series A €23M Hospitality

Investors

Number of Lead Investors
Number of Investors
2
Tmunity Therapeutics is funded by 2 investors. Be The Match BioTherapies and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Be The Match BioTherapies Series B
Lilly Asia Ventures Series A